SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-043149
Filing Date
2017-08-14
Accepted
2017-08-14 16:15:50
Documents
38
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v472033_10q.htm 10-Q 395195
2 EXHIBIT 31.1 v472033_ex31-1.htm EX-31.1 7130
3 EXHIBIT 31.2 v472033_ex31-2.htm EX-31.2 7154
4 EXHIBIT 32.1 v472033_ex32-1.htm EX-32.1 3789
5 EXHIBIT 32.2 v472033_ex32-2.htm EX-32.2 3771
  Complete submission text file 0001144204-17-043149.txt   3471393

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20170630.xml EX-101.INS 692953
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20170630.xsd EX-101.SCH 32400
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20170630_cal.xml EX-101.CAL 18233
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20170630_def.xml EX-101.DEF 177570
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20170630_lab.xml EX-101.LAB 228217
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20170630_pre.xml EX-101.PRE 196276
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 171030307
SIC: 2836 Biological Products, (No Diagnostic Substances)